Discover 2,413 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,413
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: McLean VA, Baltimore MD, Philadelphia PA,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
for
Episodic Migraine
Location: McLean VA, Baltimore MD, Philadelphia PA,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018700
Phase3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Washington D.C. DC, Baltimore MD, Martinsburg WV,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Washington D.C. DC, Columbia MD, Glen Burnie MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase2, Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT06059638
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
for
Colorectal Cancer
Location: Northwest WA, Baltimore MD, Newark DE, Richmond VA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06562543
Recruiting
Active & Responsive
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
for
Sickle Cell Disease
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06439082
Phase3, Recruiting
Active & Responsive
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Carl Allen
Sex: All
Age: 0+
Code: NCT04079179
Phase2, Recruiting
Active & Responsive
Advancing Transplantation Outcomes in Children
for
Kidney Transplant
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 13 - 20
Code: NCT06055608
Phase2, Recruiting
Active & Responsive
BBD Longitudinal Study of Osteogenesis Imperfecta
for
Osteogenesis Imperfecta
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: Baylor College of Medicine
Sex: All
Age: 0+
Code: NCT02432625
Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase3, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Washington D.C. DC, Baltimore MD, Hershey PA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase3, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Washington D.C. DC, Annapolis MD, Dover DE,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Location: Rockville MD, Falls Church VA, Fairfax VA, Oxon Hill MD,
Sponsor: Amgen
Sex: All
Age: 45 - 70+
Code: NCT07037433
Phase3, Recruiting
Active & Responsive
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
for
Obstructive Sleep Apnea (OSA)
Location: Rockville MD, Cincinnati OH, Anderson SC, Memphis TN,
Sponsor: Incannex Healthcare Ltd
Sex: All
Age: 18 - 65
Code: NCT07635563
Phase2, Recruiting
Active & Responsive
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Arlington VA, Beltsville MD, Falls Church VA, Bowie MD,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase3, Recruiting
Active & Responsive
Retinal Blood Flow and Autoregulation
for
Glaucoma
Location: Silver Spring MD, Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 70+
Code: NCT05344274
Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Arlington VA, Fairfax VA, Reston VA, Woodbridge VA,